New publication about COVID-19 vaccine on eBioMedicine

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate

The COVID19-101 project in partnership with the Institut Pasteur aimed to characterize the immune response induced by the SARS-CoV-2 vaccine candidate as part of a phase I clinical study.

This work resulted in a publication in eBioMedicine.

https://doi.org/10.1016/j.ebiom.2021.103810